Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Glutamate-Ammonia Ligase
Nipp, Ryan
Postcards as Topic
Risk adjusted therapy in chronic lymphocytic leukemia: a phase II cancer trials Ireland (CTRIAL-IE [ICORG 07-01]) study of fludarabine, cyclophosphamide, and rituximab therapy evaluating response adapted, abbreviated frontline therapy with FCR in non-del(17p) CLL.
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med. 2015 Dec 17; 373(25):2425-37.
View in:
PubMed
subject areas
Adenine
Aged
Antineoplastic Agents
Chlorambucil
Diarrhea
Disease-Free Survival
Fatigue
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Neutropenia
Piperidines
Pyrazoles
Pyrimidines
Survival Analysis
authors with profiles
Michael Joseph O'Dwyer